春光药装
(838810)
| 流通市值：1.85亿 | | | 总市值：4.89亿 |
| 流通股本：2590.70万 | | | 总股本：6850.00万 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 93,259,619.79 | 95,552,025.71 | 123,868,801.3 | 130,296,707.96 |
| 应收票据及应收账款 | 60,838,005.06 | 64,181,696.76 | 72,497,838.48 | 88,762,086.22 |
| 其中：应收票据 | 2,711,638.4 | 4,585,114.03 | 4,568,421.19 | 4,767,876.39 |
| 应收账款 | 58,126,366.66 | 59,596,582.73 | 67,929,417.29 | 83,994,209.83 |
| 应收款项融资 | 923,000 | 2,424,105.84 | 663,266 | 913,534 |
| 预付款项 | 1,965,976.43 | 1,550,815.91 | 5,018,390.12 | 6,678,934.43 |
| 其他应收款合计 | 3,113,700.21 | 959,852.49 | 2,172,865.03 | 3,455,617.9 |
| 存货 | 104,002,797.55 | 82,092,687.19 | 82,429,515.46 | 80,714,262.17 |
| 合同资产 | 12,691,184.19 | 17,446,009.64 | 20,680,477.99 | 20,212,088.02 |
| 其他流动资产 | 10,719,065.75 | 8,689,622.86 | 4,211,365.96 | 189,821.07 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 290,555,082.54 | 273,910,270.25 | 312,549,628.18 | 332,224,869.57 |
| 非流动资产: | | | | |
| 固定资产 | 36,668,734.14 | 38,191,822.91 | 38,350,448.55 | 39,641,860.8 |
| 在建工程 | 102,156,961.26 | 101,356,343.76 | 49,470,944.45 | 4,966,640.74 |
| 使用权资产 | 1,017,970.61 | 1,102,801.49 | - | - |
| 无形资产 | 36,255,738.97 | 36,512,097.72 | 36,172,767.85 | 36,289,701.81 |
| 长期待摊费用 | 4,916.67 | 7,666.68 | 492,188.47 | 269,454.1 |
| 递延所得税资产 | 7,052,879.6 | 6,556,850.01 | 6,848,177.74 | 6,790,053.22 |
| 其他非流动资产 | 1,140,824 | 453,600 | 16,800,712 | 44,703,329.21 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 184,298,025.25 | 184,181,182.57 | 148,135,239.06 | 132,661,039.88 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 474,853,107.79 | 458,091,452.82 | 460,684,867.24 | 464,885,909.45 |
| 流动负债: | | | | |
| 短期借款 | 40,955,897.22 | 28,366,477.81 | 33,366,477.81 | 32,924,522.81 |
| 应付票据及应付账款 | 39,328,037.18 | 30,719,712.1 | 33,359,450.52 | 29,998,982.34 |
| 其中：应付票据 | 1,468,662.99 | 1,906,862.99 | - | - |
| 应付账款 | 37,859,374.19 | 28,812,849.11 | 33,359,450.52 | 29,998,982.34 |
| 合同负债 | 11,829,159.04 | 11,286,282.25 | 10,078,467.04 | 14,863,863.82 |
| 应付职工薪酬 | 3,197,556.86 | 3,099,119.39 | 2,533,075.92 | 2,545,121.75 |
| 应交税费 | 614,454.79 | 1,512,597.79 | 3,061,307.77 | 6,307,977.97 |
| 其他应付款合计 | 9,962,983.75 | 10,240,602.19 | 1,255,744.25 | 1,460,556.77 |
| 其他流动负债 | 4,249,429.08 | 4,572,593.12 | 5,878,621.91 | 5,700,178.69 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 110,137,517.92 | 89,797,384.65 | 89,533,145.22 | 93,801,204.15 |
| 非流动负债: | | | | |
| 长期借款 | 46,400,000 | 46,400,000 | 46,900,000 | 46,900,000 |
| 租赁负债 | 1,029,798.46 | 1,109,183.25 | - | - |
| 递延收益 | 36,681,245.9 | 36,759,611.6 | 36,837,977.3 | 36,916,343 |
| 递延所得税负债 | 880,958.42 | 902,166.14 | 129,034.86 | 129,034.86 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 84,992,002.78 | 85,170,960.99 | 83,867,012.16 | 83,945,377.86 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 195,129,520.7 | 174,968,345.64 | 173,400,157.38 | 177,746,582.01 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 68,500,000 | 68,500,000 | 68,500,000 | 68,500,000 |
| 资本公积 | 138,882,925.35 | 138,780,940.35 | 138,678,955.35 | 138,576,970.35 |
| 盈余公积 | 12,091,110.59 | 12,091,110.59 | 12,495,077.07 | 12,448,887.72 |
| 未分配利润 | 60,431,121.91 | 63,772,960.72 | 67,709,223.1 | 67,612,190.13 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 279,905,157.85 | 283,145,011.66 | 287,383,255.52 | 287,138,048.2 |
| 少数股东权益 | -181,570.76 | -21,904.48 | -98,545.66 | 1,279.24 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 279,723,587.09 | 283,123,107.18 | 287,284,709.86 | 287,139,327.44 |
| 负债和股东权益合计 | 474,853,107.79 | 458,091,452.82 | 460,684,867.24 | 464,885,909.45 |
| 公告日期 | 2024-04-25 | 2024-04-25 | 2023-10-27 | 2023-08-21 |
| 审计意见(境内) | | 标准无保留意见 | | |